Cardiovascular Toxicology

, Volume 6, Issue 3–4, pp 211–221

Serum cardiac troponin T as a biomarker for acute myocardial injury induced by low doses of isoproterenol in rats

  • Eugene Herman
  • Jun Zhang
  • Alan Knapton
  • Steven E. Lipshultz
  • Nader Rifai
  • Frank Sistare


In rats, high doses of isoproterenol (Iso) have caused acute myocardial lesions and increased serum levels of cardiac troponin T (cTnT). We determined whether low doses of lso also cause cardiac alterations and whether monitoring cTnT levels could detect this injury. Rats received 8 to 500 μg/kg lso and were followed for 3 to 48 h. Lesion severity was scored from 0 to 5. Within 3 h, mean cTnT was elevated in all 29 rats receiving 8, 16, 32, or 64 μg/kg lso (0.20 to 0.28 ng/mL), but minimal lesions occurred in only two animals. However, by 6 h, cardiac lesions and increases in serum cTnT (mean=0.21 to 0.23 ng/mL) were observed in all 14 rats receiving 32 or 64 μg/kg lso. Doses of 125, 250, or 500 μg/kg lso caused more significant increases in cTnT levels and marked myocardial lesions that reached a peak 3 to 6 h after dosing. The magnitude of the lesions and cTnT levels declined between 12 and 48 h post treatment. Thus, a range of low lso doses can cause myocardial lesions, and serum cTnT levels can be monitored to detect the onset and progression of this type of acute cardiac injury in rats; however, careful attention to dosing and sampling times is critical to interpretation.

Index Entries

Cardiac troponin T isoproterenol myocardial damage low dose 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Chappel, C. I., Rona, G., Balazs, T., et al. (1959). Severe myocardial necrosis produced by isoproterenol, in the rat. Arch., Int. Pharmacodyn. Ther. 122:123–128.Google Scholar
  2. 2.
    Rona, G., Chappel, C. I., Balazs, T., et al. (1959). An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch. Pathol. 67: 448–453.Google Scholar
  3. 3.
    Rona, G., Kahn, D. S., and Chappel, C. I. (1963). Studies on the infarct-like myocardial necrosis produced by isoproterenol. A review. Rev. Can. Biol. 22:241–255.PubMedGoogle Scholar
  4. 4.
    Davies, M. J. (1977). The pathology of mycardial ischaemia. J. Clin. Pathol. Suppl. (R. Coll. Pathol.) 11:45–52.Google Scholar
  5. 5.
    Mair, J. (1997). Progress in myocardial damage detection: new biochemical markers for clinicians. Cri. Rev. Clin. Lab. Sci. 34:1–66.CrossRefGoogle Scholar
  6. 6.
    Katus, H.A., Remppis, A., Neuman, F. J., et al. (1991). Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 83:902–912.PubMedGoogle Scholar
  7. 7.
    Adams, J. E. III, Bodor, G. S., Davila-Roman, V. G., et al. (1993). Cardiac troponin I. A marker with high specificity for cardiac, injury. Circulation 88:101–106.PubMedGoogle Scholar
  8. 8.
    O'Brien, P. J., Daweron, G. W., Beck, M. L., et al. (1997). Troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab. Animal Sci. 147:486–495.Google Scholar
  9. 9.
    O'Brien, P. J., Landt, Y., and Ladenson, J. H. (1997). Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay. Clin Chem. 43:2333–2338.PubMedGoogle Scholar
  10. 10.
    O'Brien, P. J., Dameron, G. W., Beck, M. L., et al. (1998). Differential reactivity of cardiac and skeletal muscle from various species in two generations of cardiac troponin-T immunoassays. Res. Vet. Sci. 65:135–137.PubMedCrossRefGoogle Scholar
  11. 11.
    Bleuel, H., Deschl, U., Bertsch, T., et al. (1995). Diagnostic efficiency of troponin T measurements in rats with experimental myocardial damage. Exp. Toxicol. Pathol. 47: 121–127.PubMedGoogle Scholar
  12. 12.
    Bertsch, T., Bleuel, H., Aufenanger, J., et al. (1997). Comparison of cardiac troponin T and cardiac troponin I concentrations in peripheral blood during orciprenaline induced tachycardia in rats. Exp. Toxicol. Pathol. 49:467–468.PubMedGoogle Scholar
  13. 13.
    Bertsch, T., Bleuel, H., Deschl, U., et al. (1999). A new sensitive cardiac troponin T rapid test (TROPT) for the detection of experimental acute damage in rats. Exp. Toxicol. Pathol. 51:565–569.PubMedGoogle Scholar
  14. 14.
    Bertinchant, J. P., Robert, E., Polge, A., et al. (2000). Comparison of the diagnostic value of cardiac troponin I and T determinations for detecting early myocardial damage and the relationship with histological findings after isoproterenol-induced cardiac injury. Clin. Chimica Acta 298: 13–28.CrossRefGoogle Scholar
  15. 15.
    Bartsch, V. W., Roesch, E., Hebold, G., et al. (1974). Einbeitrag zur differenzi erang zwischein echter und scheinbarer, β-rezeptoren blockade am herzen. Arzneim-Forsch (Drug Res.) 24:303–308.Google Scholar
  16. 16.
    Mueller-Bardorf, M., Hallermayer, K., Schroder, A., et al. (1997). Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin. Chem. 43:458–466.Google Scholar
  17. 17.
    Noronha-Dutra, A. A., Steen, E. M., and Woolf, N. (1984). The early changes induced by isoproterenol in the endocardium and adjacent myocardium. Am. J. Pathol. 114: 231–239.PubMedGoogle Scholar

Copyright information

© Humana Press Inc 2006

Authors and Affiliations

  • Eugene Herman
    • 4
  • Jun Zhang
    • 4
  • Alan Knapton
    • 4
  • Steven E. Lipshultz
    • 1
  • Nader Rifai
    • 2
  • Frank Sistare
    • 4
    • 3
  1. 1.Department of PediatricsUniversity of MiamiMiller School of MedicineMiami
  2. 2.Children's HospitalHarvard Medical SchoolBoston
  3. 3.Merck Research LabsWest Point
  4. 4.Division of Applied Pharmacology Research (HFD-910)Center for Drug Evaluation and Research Fod and Drug AdministrationSilver Spring

Personalised recommendations